Sat.Nov 20, 2021 - Fri.Nov 26, 2021

New Merck study results raise questions about its COVID-19 pill

Bio Pharma Dive

Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug, which will be evaluated at a meeting Tuesday

Trials 281

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

SUMMARY: The U.S. needs to take substantial steps to address the high costs of cancer drugs. From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… … Does the question become how much is a month(s) of other life worth?


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equal Parts Caregiver and Advocate: Clinical Trials from the Caregiver’s Point of View


“There are only four kinds of people in the world: Those who have been caregivers, those who are currently caregivers, those who will be caregivers, and those who will need caregivers.”. Roslyn Carter.

How far away is help? Researchers map access to HIV care


In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5

Lessons in Supply Chain Digitization from PepsiCo and Conagra

Speaker: Craig Weiss, ConAgra Brands; Mari Roberts PepsiCo; and Matt Elenjickal, FourKites

Supply chain digitalization is key to success as market volatility, widespread disruption & stiff competition for consumer dollars puts pressure on every aspect of the supply chain. Register to hear how 2 global brands are accelerating digital transformation and increasing efficiency & automation throughout their operations.

Neurocrine stocks up on a biotech's psychiatric drugs

Bio Pharma Dive

A new deal with Sosei Heptares hands Neurocrine a "broad portfolio" of drugs for schizophrenia, dementia and other neuropsychiatric disorders

Drugs 265

Does CVS have a crystal ball into the future?

World of DTC Marketing

SUMMARY: CVS announced its plans to begin closing its doors –about 900 locations across the country. They know the future isn’t about selling 20 kinds of shampoos and vitamins.

More Trending

How sugar-loving microbes could help power future cars


BUFFALO, N.Y. — It sounds like modern-day alchemy: Transforming sugar into hydrocarbons found in gasoline. Credit: Douglas Levere / University at Buffalo BUFFALO, N.Y. — It sounds like modern-day alchemy: Transforming sugar into hydrocarbons found in gasoline.

Bluebird, after delays, gets speedy FDA review for beta thalassemia gene therapy

Bio Pharma Dive

The regulator will decide whether to approve Bluebird's treatment by next May, but its evaluation begins more than a year later than the biotech first hoped

Insulin costs ignore the root cause of diabetes

World of DTC Marketing

OPENING: As the NY Times recently reported , obesity is the leading cause of mortality in the United States. Obesity costs the nation $1.72 trillion every year.

LMC Manna, IACT Health join in integrated research network

Outsourcing Pharma

The alliance is aimed at expanding service to pharmaceutical firms and other partners, and advancing treatment options for patients across North America. Clinical Development

3 Ways End-to-End Visibility Helps Minimize the Risks of Ocean Freight

Download this playbook to learn how end-to-end visibility helps to mitigate risk associated with the ocean freight market.

Deep learning algorithms assist in identifying microplastics in human body


The research is supported by the Russian Science Foundation (grant 21-73-00097). Credit: Kazan Federal University The research is supported by the Russian Science Foundation (grant 21-73-00097). “If

With safety a concern, Merck, Gilead pause study of HIV drugs

Bio Pharma Dive

Out of an "abundance of caution," the companies halted enrollment in a trial evaluating the combination of Merck's islatravir and Gilead's lenacapavir

Trials 236

New COVID variant ‘may sidestep vaccine protection’

Pharma Phorum

A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines.

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

BioPharma Reporter

A new clinical trial of heterologous â or âmix-and-matchâ â combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations. Bio Developments

4 Silver Linings of the Chaotic Ocean Freight Market

Speaker: Peter Tirschwell, Chris Stauber, Sarah Barnes Humphrey, and Audrey Ross

Join this webinar exploring the silver linings that have emerged from the chaotic ocean freight market. The discussion will highlight solutions that prioritize digitization and build a more efficient international supply chain. Jan 25 at 10am CT.

Machine learning solves the who’s who problem in NMR spectra of organic crystals


Solid-state nuclear magnetic resonance (NMR) spectroscopy—a technique that measures the frequencies emitted by the nuclei of some atoms exposed to radio waves in a strong magnetic field—can be used to determine chemical and 3D structures as well as the dynamics of molecules and materials.


AstraZeneca, after years of delays, opens UK hub meant to recharge drug research

Bio Pharma Dive

Formally unveiled five years after originally planned, the $1 billion headquarters will become the British drugmaker's second-largest R&D center by headcount

Time for change: PhRMA survey shows insurance creates barriers to healthcare in US

Pharma Phorum

Health insurance is not enough to provide the necessary affordable access to care for the US’ most vulnerable, finds new PhRMA report. For too many Americans, insurance coverage is not providing the health security it’s meant to.

GreenLight Biosciences and Samsung Biologics to build mRNA vaccine manufacturing capacity

BioPharma Reporter

GreenLight Biosciences and CDMO Samsung Biologics have announced a partnership agreement, with Samsung Biologics to manufacture GreenLightâs messenger RNA COVID-19 vaccine candidate at commercial scale. Upstream Processing

RNA 87

The Smart Data Revolution: How AB InBev Drives Efficiency with Visibility Data

Speaker: AB InBev and FourKites

Register for our upcoming webinar to learn how leveraging the right data to make quick, well-informed decisions is the key to success in supply chain & logistics. Join FourKites and AB InBev to learn what’s possible with a data-driven supply chain strategy & real-time transportation visibility.

A tough attachment between rotator cuff, bone achieved through unique fibrous architecture


Engineers often use nature to inspire new materials and designs. A discovery by a multi-institutional team of researchers and engineers about how tendon and bone attach in the shoulder joint has uncovered previously unsuspected engineering strategies for attaching dissimilar materials.

Pfizer, BioNTech to seek full approval as COVID-19 vaccine efficacy holds up in young teens

Bio Pharma Dive

Four months after vaccination, no 12- to 15-year-olds in the companies' clinical trial developed COVID-19, compared to 30 who received a placebo

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

Pharma Phorum

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality.

Seizure Drug from Sagent Pharmaceuticals Recalled Over Faulty Seal


Sagent Pharmaceuticals Inc. is recalling four lots of its injectable seizure medication levetiracetam over concerns of container closure integrity on vials of the drug product.

Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

In the quantum realm, not even time flows as you might expect


A team of physicists at the Universities of Bristol, Vienna, the Balearic Islands and the Institute for Quantum Optics and Quantum Information (IQOQI-Vienna) has shown how quantum systems can simultaneously evolve along two opposite time arrows – both forward and backward in time.


Nanomilling: an optimal solution for poorly soluble, challenging APIs

Bio Pharma Dive

A versatile technique to ensure your drug is ready on time for your first-in-human clinical trial

Re-envisioning mental health treatment using clinical VR

Pharma Phorum

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR) therapy BRAVEMIND is changing PTSD treatment and how pharma can leverage clinical VR.

EMA approves Pfizer-BioNTech COVID-19 vaccine for young children

Pharma Times

The Food and Drug Administration (FDA) granted approval for emergency use of the Comirnaty vaccine in children in October 2021

Drugs 87

Minimizing Retail Supply Chain Disruptions in 2021 and Beyond

Speaker: Izaac Moran, Customer Success Manager, FourKites; Glenn Koepke, SVP of Customer Success, FourKites; and featuring interviews with supply chain experts from Dollar Tree and Best Buy

Register for our upcoming webinar to see how savvy retailers including Dollar Tree and Best Buy are leveraging real-time visibility across their end-to-end supply chains in creative ways to drive agility and thrive in today’s unpredictable environment.

Taking new aim at COVID-19


DURHAM, N.C. — To the untrained eye, the loops, kinks and folds in the single strand of RNA that makes up the coronavirus genome look like a jumble of spaghetti or tangled yarn.

RNA 83

GSK dives into NASH, RNA interference with Arrowhead deal

Bio Pharma Dive

GSK has secured rights to a genetic medicine in early-stage human testing for NASH, a disease thought to affect millions of people and which has proven to be a tough target for drugmakers

RNA 169

FDA clears Takeda drug for post-transplant CMV infections

Pharma Phorum

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complications and even death.

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II


A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.